Study guide

5.2 Traumatic Brain Injury (TBI) and Intracranial Pressure (ICP) Management

Certified Flight Paramedic FP-C

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Safety and Transport

1.1 Pre-Flight Operations and Equipment Stowing 1.2 Scene Safety and Landing Zone Management 1.3 In-Flight Emergency Response and Abort Protocols 1.4 Post-Incident Survival and Rescue Operations

2 Chapter 2: Flight Physiology

2.1 Gas Laws in Transport Medicine 2.2 Hypoxia: Classification and Corrective Actions 2.3 Environmental Stressors of Flight and Cabin Pressurization

3 Chapter 3: Airway, Anesthesia, and Analgesics

3.1 Advanced Airway Assessment and Difficult Airway Algorithms 3.2 Rapid Sequence Intubation (RSI) and Medication Selection 3.3 Mechanical Ventilation: Modes, Settings, and Monitoring 3.4 Transport Oxygen Systems and Duration Calculations 3.5 Anaesthetics and Induction Agents 3.6 Neuromuscular Blocking Agents 3.7 Analgesics and Vasoactive Sedative Titration

4 Chapter 4: Medical Emergencies

4.1 Respiratory Failure Pathologies (ARDS, Asthma, COPD) 4.2 Sepsis and Septic Shock Management 4.3 Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS) 4.4 Toxicological Emergencies and Overdose Antidotes 4.5 Environmental Emergencies: Core Temperature Control (Hypo/Hyperthermia) 4.6 Adrenal Crisis and Incretin/Endocrine Emergencies

5 Chapter 5: Neurological Emergencies

5.1 Neurological Assessment and GCS Motor Scales 5.2 Traumatic Brain Injury (TBI) and Intracranial Pressure (ICP) Management 5.3 Stroke Care: Hemorrhagic vs. Ischemic Thrombectomy Candidates 5.4 Status Epilepticus Seizure Protocols 5.5 Spinal Trauma and Spinal Cord Syndromes

6 Chapter 6: Cardiac Emergencies

6.1 Acute Coronary Syndrome (ACS) and 12-Lead Interpretation 6.2 Dysrhythmias: Bradycardias and High-Grade AV Blocks 6.3 Cardiogenic Shock and Systemic Vascular Resistance (SVR) 6.4 Vasoactive Medication Titration (Norepinephrine, Epinephrine, Dopamine) 6.5 Mechanical Circulatory Support (IABP and ECMO Transport) 6.6 Post-Cardiac Arrest Care and Targeted Temperature Management

7 Chapter 7: Trauma/Burn Resuscitation

7.1 Damage Control Resuscitation and the Lethal Triad 7.2 Hemorrhage Control and Massive Transfusion Protocols (MTP) 7.3 Penetrating Thoracic Trauma and Cardiac Tamponade (Beck's Triad) 7.4 Blunt Force Deceleration Injuries (Traumatic Aortic Rupture) 7.5 Burn Physiology: Calculations (Parkland Formula) and Escharotomy

8 Chapter 8: Maternal, Fetal, and Neonatal Emergencies

8.1 Perinatal Transport and Maternal Complications 8.2 Ob/Gyn Emergencies and Emergency Delivery 8.3 Neonatal Resuscitation Program (NRP) Standards

9 Chapter 9: Pediatric Emergencies

9.1 Pediatric Assessment Triangle and Pathophysiology 9.2 Pediatric Airway and Ventilatory Management 9.3 Pediatric Pharmacology and Dosing Calculations 9.4 Pediatric Trauma and Resuscitation

10 Chapter 10: Professional Considerations

10.1 CAMTS Standards and Quality Metrics 10.2 Medical Ethics and Transport Law (EMTALA) 10.3 Crew Resource Management (CRM) and Human Factors

5.2 Traumatic Brain Injury (TBI) and Intracranial Pressure (ICP) Management

Key Takeaways Explain This Topic AI

The Monroe-Kellie Doctrine dictates that the skull is a rigid vault; an increase in brain tissue, blood, or CSF volume must be compensated by displacement of the others, or ICP rises exponentially.

Cerebral Perfusion Pressure (CPP) is calculated as MAP - ICP; critical transport targets require maintaining CPP between 60 to 70 mmHg and keeping ICP below 22 mmHg.

Hyperosmolar therapy employs Mannitol (requires inline filter; contraindicated in hypotension) or Hypertonic Saline (preferred in hemodynamically unstable patients to support SBP and MAP).

Routine hyperventilation is strictly contraindicated due to risk of cerebral ischemia; mild hyperventilation (PaCO2 30-35 mmHg) is reserved as a temporary measure during active herniation.

Resuscitation targets to prevent secondary brain injury ('H bombs') include SBP >= 100-110 mmHg, MAP >= 80 mmHg, SpO2 >= 90%, and strict avoidance of hypoxia or hypotension.

Last updated: July 2026

  • Traumatic Brain Injury (TBI) and Intracranial Pressure (ICP) Management
  • Pathophysiology of Brain Injury: Primary vs. Secondary

Managing traumatic brain injury (TBI) in transport medicine requires understanding the distinction between primary and secondary brain injury. Primary brain injury occurs at the moment of impact and represents the mechanical disruption of neural tissues, such as diffuse axonal injury, contusions, and subdural or epidural hematomas.

The primary goal of critical care transport is to mitigate secondary brain injury, which represents the physiological and biochemical cascades that occur hours after the trauma. It is driven by systemic insults that worsen cerebral ischemia. The Brain Trauma Foundation (BTF) highlights the 'H Bombs' of TBI as preventable causes of secondary injury:

Hypoxia: A single episode of hypoxia (SpO2 < 90% or PaO2 < 60 mmHg) doubles TBI mortality.

Hypotension: A single systolic blood pressure reading of < 90 mmHg (or < 100-110 mmHg based on age) doubles mortality.

Hyperventilation: Routine hyperventilation causes vasoconstriction, reducing cerebral blood flow to ischemic levels.

Hypoglycemia/Hyperglycemia: Hypoglycemia causes cellular energy failure, while hyperglycemia exacerbates cerebral lactic acidosis.

The Monroe-Kellie Doctrine and ICP Target Ranges

The Monroe-Kellie Doctrine describes intracranial dynamics. The skull is a rigid, non-compliant bony vault. Its internal volume is constant and comprises three components:

Brain Parenchyma: ~80% of volume.

Cerebral Blood Volume (CBV): ~10% of volume.

Cerebrospinal Fluid (CSF): ~10% of volume.

Because volume is fixed, an increase in any component must be offset by a decrease in the others. Compensatory mechanisms include displacing CSF into the spinal canal and shunting venous blood out of the skull via the jugular veins. Once these reservoirs are exhausted, even a minute volume increase leads to an exponential rise in Intracranial Pressure (ICP).

Normal ICP: 5 to 15 mmHg.

Pathological ICP: > 20 mmHg.

Treatment Threshold: Guidelines recommend initiating ICP-lowering therapies when ICP exceeds 22 mmHg .

Cerebral Perfusion Pressure (CPP) Calculations and Targets

Cerebral Perfusion Pressure (CPP) is the net pressure gradient driving blood flow to the brain, calculated as: CPP = MAP - ICP (or CPP = MAP - CVP if CVP is higher than ICP). MAP is calculated as: MAP = DBP + 1/3(SBP - DBP).

Target CPP: The optimal range is 60 to 70 mmHg .

CPP < 50 mmHg: Results in critical cerebral ischemia, leading to tissue infarction.

CPP > 70 mmHg: Should be avoided, as it can cause hyperperfusion, exacerbate cerebral edema, and increase the risk of acute respiratory distress syndrome (ARDS) due to systemic fluid loading.

Hyperosmolar Therapy: Mannitol vs. Hypertonic Saline

When a patient exhibits signs of elevated ICP, hyperosmolar therapy is indicated to draw water out of the swollen brain tissue.

Mannitol (20% solution)

Mannitol is an osmotic diuretic that acts via a rheological effect (decreases blood viscosity, causing reflex vasoconstriction and lowering ICP) and an osmotic effect (draws water from the brain parenchyma into the intravascular space for renal excretion).

Dose: 0.25 to 1.0 g/kg IV bolus over 10-20 minutes.

Administration: Must be run through a 0.22-micron in-line filter because mannitol can crystallize at room temperature.

Contraindications: Hypotension (SBP < 90 mmHg) is a strict contraindication, as the osmotic diuresis will worsen hypovolemia and cause cardiovascular collapse. It is also contraindicated in renal failure.

Hypertonic Saline (HTS - 3% or 23.4%)

Hypertonic Saline draws water out of brain tissue without causing profound diuresis. It expands intravascular volume, increases MAP, improves cardiac output, and restores normal neuronal membrane potentials.

Dose (3%): 250 to 500 mL IV bolus, or run as an infusion at 1 to 2 mL/kg/hr.

Dose (23.4%): 30 mL slow IV bolus over 10 to 20 minutes (the 'hypertonic bullet') via a central line.

Preference: HTS is the agent of choice in hemodynamically unstable or hypotensive patients, as it supports blood pressure while lowering ICP.

Carbon Dioxide Management and Ventilation Limits

Carbon dioxide (CO2) is a potent regulator of cerebral blood flow (CBF). Cerebral blood vessels are highly sensitive to changes in PaCO2:

Hypercapnia (PaCO2 > 45 mmHg): Causes cerebral vasodilation, increasing CBV and elevating ICP.

Hypocapnia (PaCO2 < 35 mmHg): Causes cerebral vasoconstriction, reducing CBV and lowering ICP. However, excessive vasoconstriction can reduce CBF to ischemic levels.

Ventilation Guidelines

Routine Hyperventilation: Strictly contraindicated in TBI. The target PaCO2 is 35 to 45 mmHg (ETCO2 35-45 mmHg) to maintain normocapnia.

Impending Herniation: Brief, mild hyperventilation is indicated only during active brain herniation (e.g., sudden unilateral pupillary dilation, Cushing's triad, or decerebrate posturing). The target PaCO2 is 30 to 35 mmHg (ETCO2 30-35 mmHg). Hyperventilation should be discontinued as soon as the acute crisis is resolved or hyperosmolar therapy takes effect.

Target Vital Signs and Systemic Resuscitation

To optimize perfusion, the transport clinician must adhere to strict physiological targets:

Oxygenation: Maintain SpO2 >= 90% (ideally 94-98%) and PaO2 >= 60 mmHg.

Systolic Blood Pressure (SBP): Maintain SBP >= 100 mmHg for patients aged 50-69 years, and >= 110 mmHg for patients aged 15-49 or >70 years.

Mean Arterial Pressure (MAP): Maintain MAP >= 80 mmHg. If fluid resuscitation fails, vasopressors (typically Norepinephrine) should be initiated.

Sedation and Analgesia: Adequate sedation (Propofol or Midazolam) and analgesia (Fentanyl) are critical to decrease cerebral metabolic demand (CMRO2) and prevent ICP spikes. Propofol is favored due to its short half-life, allowing for rapid neurological reassessment.

Loading diagram... Monroe-Kellie Doctrine and ICP Decompensation